215 related articles for article (PubMed ID: 31484069)
1. Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21.
Sahu BS; Rodriguez P; Nguyen ME; Han R; Cero C; Razzoli M; Piaggi P; Laskowski LJ; Pavlicev M; Muglia L; Mahata SK; O'Grady S; McCorvy JD; Baier LJ; Sham YY; Bartolomucci A
Cell Rep; 2019 Sep; 28(10):2567-2580.e6. PubMed ID: 31484069
[TBL] [Abstract][Full Text] [Related]
2. The neuropeptide TLQP-21 opposes obesity via C3aR1-mediated enhancement of adrenergic-induced lipolysis.
Cero C; Razzoli M; Han R; Sahu BS; Patricelli J; Guo Z; Zaidman NA; Miles JM; O'Grady SM; Bartolomucci A
Mol Metab; 2017 Jan; 6(1):148-158. PubMed ID: 28123945
[TBL] [Abstract][Full Text] [Related]
3. The TLQP-21 peptide activates the G-protein-coupled receptor C3aR1 via a folding-upon-binding mechanism.
Cero C; Vostrikov VV; Verardi R; Severini C; Gopinath T; Braun PD; Sassano MF; Gurney A; Roth BL; Vulchanova L; Possenti R; Veglia G; Bartolomucci A
Structure; 2014 Dec; 22(12):1744-1753. PubMed ID: 25456411
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21.
Possenti R; Muccioli G; Petrocchi P; Cero C; Cabassi A; Vulchanova L; Riedl MS; Manieri M; Frontini A; Giordano A; Cinti S; Govoni P; Graiani G; Quaini F; Ghè C; Bresciani E; Bulgarelli I; Torsello A; Locatelli V; Sanghez V; Larsen BD; Petersen JS; Palanza P; Parmigiani S; Moles A; Levi A; Bartolomucci A
Biochem J; 2012 Jan; 441(1):511-22. PubMed ID: 21880012
[TBL] [Abstract][Full Text] [Related]
5. The molecular identity of the TLQP-21 peptide receptor.
Sahu BS; Nguyen ME; Rodriguez P; Pallais JP; Ghosh V; Razzoli M; Sham YY; Salton SR; Bartolomucci A
Cell Mol Life Sci; 2021 Dec; 78(23):7133-7144. PubMed ID: 34626205
[TBL] [Abstract][Full Text] [Related]
6. Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells.
Hannedouche S; Beck V; Leighton-Davies J; Beibel M; Roma G; Oakeley EJ; Lannoy V; Bernard J; Hamon J; Barbieri S; Preuss I; Lasbennes MC; Sailer AW; Suply T; Seuwen K; Parker CN; Bassilana F
J Biol Chem; 2013 Sep; 288(38):27434-27443. PubMed ID: 23940034
[TBL] [Abstract][Full Text] [Related]
7. VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.
El Gaamouch F; Audrain M; Lin WJ; Beckmann N; Jiang C; Hariharan S; Heeger PS; Schadt EE; Gandy S; Ehrlich ME; Salton SR
Mol Neurodegener; 2020 Jan; 15(1):4. PubMed ID: 31924226
[TBL] [Abstract][Full Text] [Related]
8. Changes in VGF and C3aR1 gene expression in human adipose tissue in obesity.
Koc G; Soyocak A; Alis H; Kankaya B; Kanigur G
Mol Biol Rep; 2021 Jan; 48(1):251-257. PubMed ID: 33306149
[TBL] [Abstract][Full Text] [Related]
9. Identification of a receptor for neuropeptide VGF and its role in neuropathic pain.
Chen YC; Pristerá A; Ayub M; Swanwick RS; Karu K; Hamada Y; Rice AS; Okuse K
J Biol Chem; 2013 Nov; 288(48):34638-46. PubMed ID: 24106277
[TBL] [Abstract][Full Text] [Related]
10. Photoperiodic changes in adiposity increase sensitivity of female Siberian hamsters to systemic VGF derived peptide TLQP-21.
Lisci C; Lewis JE; Daniel ZCTR; Stevenson TJ; Monnier C; Marshall HJ; Fowler M; Ebling FJP; Ferri GL; Cocco C; Jethwa PH
PLoS One; 2019; 14(8):e0221517. PubMed ID: 31465472
[TBL] [Abstract][Full Text] [Related]
11. Complement 3a receptor in dorsal horn microglia mediates pronociceptive neuropeptide signaling.
Doolen S; Cook J; Riedl M; Kitto K; Kohsaka S; Honda CN; Fairbanks CA; Taylor BK; Vulchanova L
Glia; 2017 Dec; 65(12):1976-1989. PubMed ID: 28850719
[TBL] [Abstract][Full Text] [Related]
12. TLQP-21, A VGF-Derived Peptide Endowed of Endocrine and Extraendocrine Properties: Focus on In Vitro Calcium Signaling.
Bresciani E; Possenti R; Coco S; Rizzi L; Meanti R; Molteni L; Locatelli V; Torsello A
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31878142
[TBL] [Abstract][Full Text] [Related]
13. Clearance kinetics of the VGF-derived neuropeptide TLQP-21.
Guo Z; Sahu BS; He R; Finan B; Cero C; Verardi R; Razzoli M; Veglia G; Di Marchi RD; Miles JM; Bartolomucci A
Neuropeptides; 2018 Oct; 71():97-103. PubMed ID: 29958697
[TBL] [Abstract][Full Text] [Related]
14. VGF and Its C-Terminal Peptide TLQP-62 Regulate Memory Formation in Hippocampus via a BDNF-TrkB-Dependent Mechanism.
Lin WJ; Jiang C; Sadahiro M; Bozdagi O; Vulchanova L; Alberini CM; Salton SR
J Neurosci; 2015 Jul; 35(28):10343-56. PubMed ID: 26180209
[TBL] [Abstract][Full Text] [Related]
15. TLQP-21 mediated activation of microglial BV2 cells promotes clearance of extracellular fibril amyloid-β.
Cho K; Jang YJ; Lee SJ; Jeon YN; Shim YL; Lee JY; Lim DS; Kim DH; Yoon SY
Biochem Biophys Res Commun; 2020 Apr; 524(3):764-771. PubMed ID: 32037089
[TBL] [Abstract][Full Text] [Related]
16. Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity.
Cassina V; Torsello A; Tempestini A; Salerno D; Brogioli D; Tamiazzo L; Bresciani E; Martinez J; Fehrentz JA; Verdié P; Omeljaniuk RJ; Possenti R; Rizzi L; Locatelli V; Mantegazza F
Biochim Biophys Acta; 2013 Feb; 1828(2):455-60. PubMed ID: 23122777
[TBL] [Abstract][Full Text] [Related]
17. Functional profiling of the G protein-coupled receptor C3aR1 reveals ligand-mediated biased agonism.
Rodriguez P; Laskowski LJ; Pallais JP; Bock HA; Cavalco NG; Anderson EI; Calkins MM; Razzoli M; Sham YY; McCorvy JD; Bartolomucci A
J Biol Chem; 2024 Jan; 300(1):105549. PubMed ID: 38072064
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells.
Molteni L; Rizzi L; Bresciani E; Possenti R; Petrocchi Passeri P; Ghè C; Muccioli G; Fehrentz JA; Verdié P; Martinez J; Omeljaniuk RJ; Biagini G; Binda A; Rivolta I; Locatelli V; Torsello A
Front Pharmacol; 2017; 8():167. PubMed ID: 28424618
[TBL] [Abstract][Full Text] [Related]
19. TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity.
Bartolomucci A; La Corte G; Possenti R; Locatelli V; Rigamonti AE; Torsello A; Bresciani E; Bulgarelli I; Rizzi R; Pavone F; D'Amato FR; Severini C; Mignogna G; Giorgi A; Schininà ME; Elia G; Brancia C; Ferri GL; Conti R; Ciani B; Pascucci T; Dell'Omo G; Muller EE; Levi A; Moles A
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14584-9. PubMed ID: 16983076
[TBL] [Abstract][Full Text] [Related]
20. TLQP-21 is a low potency partial C3aR activator on human primary macrophages.
Li XX; Lee JD; Lee HS; Clark RJ; Woodruff TM
Front Immunol; 2023; 14():1086673. PubMed ID: 36776827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
